ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 52 filers reported holding ALIGOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,395 | -23.1% | 39,351 | 0.0% | 0.00% | – |
| Q2 2023 | $38,210 | +11.1% | 39,351 | 0.0% | 0.00% | – |
| Q1 2023 | $34,393 | +10.7% | 39,351 | +20.7% | 0.00% | – |
| Q4 2022 | $31,068 | -13.7% | 32,604 | 0.0% | 0.00% | – |
| Q3 2022 | $36,000 | -7.7% | 32,604 | 0.0% | 0.00% | – |
| Q2 2022 | $39,000 | -90.5% | 32,604 | -83.0% | 0.00% | – |
| Q1 2022 | $412,000 | -83.0% | 191,827 | -5.9% | 0.00% | – |
| Q4 2021 | $2,420,000 | -21.3% | 203,799 | +2.8% | 0.00% | -100.0% |
| Q3 2021 | $3,076,000 | -15.2% | 198,311 | +11.4% | 0.00% | 0.0% |
| Q2 2021 | $3,629,000 | +40.4% | 178,014 | +56.6% | 0.00% | – |
| Q1 2021 | $2,584,000 | -21.7% | 113,640 | -4.8% | 0.00% | -100.0% |
| Q4 2020 | $3,301,000 | – | 119,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $47,301,000 | 15.67% |
| Pivotal bioVenture Partners Investment Advisor LLC | 876,548 | $17,873,000 | 7.04% |
| Vivo Capital, LLC | 3,547,030 | $72,306,000 | 3.13% |
| Novo Holdings A/S | 2,614,563 | $53,311,000 | 2.36% |
| ACUTA CAPITAL PARTNERS, LLC | 214,254 | $4,368,000 | 1.75% |
| Boxer Capital, LLC | 1,526,048 | $31,108,000 | 1.10% |
| VR Adviser, LLC | 408,377 | $8,325,000 | 1.01% |
| Cormorant Asset Management, LP | 905,467 | $18,458,000 | 0.63% |
| HHLR ADVISORS, LTD. | 2,165,064 | $44,135,000 | 0.45% |
| Logos Global Management LP | 212,785 | $4,339,000 | 0.36% |